相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma
Yi Que et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Blockade of myeloid-derived suppressor cell function by valproic acid enhanced anti-PD-L1 tumor immunotherapy
Adeleye O. Adeshakin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
The phosphatase PAC1 acts as a T cell suppressor and attenuates host antitumor immunity
Dan Lu et al.
NATURE IMMUNOLOGY (2020)
Immune checkpoint signaling and cancer immunotherapy
Xing He et al.
CELL RESEARCH (2020)
Inhibition of Histone Deacetylase (HDAC) Enhances Checkpoint Blockade Efficacy by Rendering Bladder Cancer Cells Visible for T Cell-Mediated Destruction
Brianna Burke et al.
FRONTIERS IN ONCOLOGY (2020)
Immunogenomic Landscape of Hematological Malignancies
Olli Dufva et al.
CANCER CELL (2020)
Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression
Reem Saleh et al.
FRONTIERS IN IMMUNOLOGY (2020)
Recent Update of HDAC Inhibitors in Lymphoma
I-Chung Chen et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Epigenetic Alterations and Biomarkers for Immune Checkpoint Inhibitors-Current Standards and Future Perspectives in Malignant Pleural Mesothelioma Treatment
Yoshie Yoshikawa et al.
FRONTIERS IN ONCOLOGY (2020)
Exhausted T cells and epigenetic status
Ziqing Zeng et al.
CANCER BIOLOGY & MEDICINE (2020)
Molecular Immunotherapy: Promising Approach to Treat Metastatic Colorectal Cancer by Targeting Resistant Cancer Cells or Cancer Stem Cells
Stefan Forster et al.
FRONTIERS IN ONCOLOGY (2020)
HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-PD-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment
Young-Dae Kim et al.
JOURNAL OF CANCER (2020)
Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survival
Oscar Bruck et al.
BLOOD ADVANCES (2020)
CD8+ T cells expand stem and progenitor cells in favorable but not adverse risk acute myeloid leukemia
Ramin Radpour et al.
LEUKEMIA (2019)
Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: Novel Combinations and Therapeutic Targets
Maximilian Stahl et al.
CURRENT ONCOLOGY REPORTS (2019)
The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia
Patrick Williams et al.
CANCER (2019)
Histone deacetylase inhibition up-regulates MHC class I to facilitate cytotoxic T lymphocyte-mediated tumor cell killing in glioma cells
Ting Sun et al.
JOURNAL OF CANCER (2019)
Memory CD8+ T cells support the maintenance of hematopoietic stem cells in the bone marrow
Sulima Geerman et al.
HAEMATOLOGICA (2018)
Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumors
Jooeun Bae et al.
LEUKEMIA (2018)
Memory CD8+ T cells support the maintenance of hematopoietic stem cells in the bone marrow
Sulima Geerman et al.
HAEMATOLOGICA (2018)
Bifunctional PD-1 x αCD3 x αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemia
Monika Herrmann et al.
BLOOD (2018)
Tcf1 and Lef1 transcription factors establish CD8+ T cell identity through intrinsic HDAC activity
Shaojun Xing et al.
NATURE IMMUNOLOGY (2016)
A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression
Yoshikane Kikushige et al.
CELL STEM CELL (2015)
Blocking programmed cell death 1 in combination with adoptive cytotoxic T-cell transfer eradicates chronic myelogenous leukemia stem cells
C. Riether et al.
LEUKEMIA (2015)
Tyrosine kinase inhibitor-induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signaling
Carsten Riether et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
On being less tolerant: Enhanced cancer immunosurveillance enabled by targeting checkpoints and agonists of T cell activation
Alexander M. Lesokhin et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Regulation of hematopoietic and leukemic stem cells by the immune system
C. Riether et al.
CELL DEATH AND DIFFERENTIATION (2015)
Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
H. Yang et al.
LEUKEMIA (2014)
Alterations of immune response of non-small cell lung cancer with Azacytidine
John Wrangle et al.
ONCOTARGET (2013)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression
Sabine Mumprecht et al.
BLOOD (2009)
PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model
Long Zhang et al.
BLOOD (2009)
Glucocorticoid-Induced Tumor Necrosis Factor Receptor-Related Protein Ligand Subverts Immunosurveillance of Acute Myeloid Leukemia in Humans
Tina Baessler et al.
CANCER RESEARCH (2009)
CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Siddhartha Jaiswal et al.
CELL (2009)
Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity
KJ Hope et al.
NATURE IMMUNOLOGY (2004)
CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells
MP Pistillo et al.
BLOOD (2003)
分享论文
